Insmed Inc’s recent filing unveils that its Chief Medical Officer Flammer Martina M.D. unloaded Company’s shares for reported $95108.0 on Jan 14 ’25. In the deal valued at $68.72 per share,1,384 shares were sold. As a result of this transaction, Flammer Martina M.D. now holds 100,165 shares worth roughly $7.69 million.
Then, Adsett Roger sold 1,457 shares, generating $100,125 in total proceeds. Upon selling the shares at $68.72, the Chief Operating Officer now owns 146,082 shares.
Before that, Schaeffer Orlov S Nicole sold 872 shares. Insmed Inc shares valued at $59,924 were divested by the Chief People Strategy Officer at a price of $68.72 per share. As a result of the transaction, Schaeffer Orlov S Nicole now holds 97,083 shares, worth roughly $7.45 million.
Truist initiated its Insmed Inc [INSM] rating to a Buy in a research note published on April 23, 2024; the price target was $48. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Wells Fargo began covering INSM with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of INSM
On Tuesday, Insmed Inc [NASDAQ:INSM] saw its stock jump 5.85% to $76.75. Over the last five days, the stock has gained 11.34%. Insmed Inc shares have risen nearly 11.17% since the year began. Nevertheless, the stocks have risen 169.87% over the past one year. While a 52-week high of $80.53 was reached on 01/21/25, a 52-week low of $21.92 was recorded on 01/10/25. SMA at 50 days reached $71.45, while 200 days put it at $62.64.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 74.01, which if violated will result in even more drops to 71.28. On the upside, there is a resistance level at 78.32. A further resistance level may holdings at 79.90. The Relative Strength Index (RSI) on the 14-day chart is 66.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.66, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 2.62%. Stochastics %K at 93.00% indicates the stock is a selling.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2024-12-31, growing by 2.82 million shares to a total of 15.44 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 12.62 million shares. There was a rise of 18.29%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 26, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
